Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib
(NASDAQ: IKT) Delayed: 2.34 +0.01 (0.43%)
Previous Close $2.33    52 Week High $ 
Open $2.37    52 Week Low $ 
Day High $2.39    P/E N/A 
Day Low $2.32    EPS $ 
Volume 303,243